CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 66.16% | -0.16% | -21.65% | |
| 2 | BOLDEUR | Audentes Therapeutics INC | Stock-Other | 14.36% | — | — | |
| 3 | OCUL | Ocular Therapeutix INC | Stock-Other | 4.67% | — | — | |
| 4 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 4.39% | — | — | |
| 5 | AKAOQ | Achaogen INC | Stock-Other | 3.46% | — | — | |
| 6 | IMRX | Immuneering Corporation | Stock-Other | 3.13% | — | — | |
| 7 | ✓ | Second Sight Med Prods INC | Stock-Other | 2.33% | — | — | |
| 8 | CLVSEUR | Clovis Oncology INC | Stock-Other | 1.44% | — | — | |
| 9 | ✓ | Opgen, Inc. | Stock-Other | 0.06% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BOLDEUR | Audentes Therapeutics INC | +2.8% | — | Unchanged |
| 2 | IMRX | Immuneering Corporation | +0.8% | — | Unchanged |
| 3 | OCUL | Ocular Therapeutix INC | +0.1% | — | Unchanged |
| 4 | CBAYUSD | Cymabay Therapeutics INC | 0% | — | Unchanged |
| 5 | CLVSEUR | Clovis Oncology INC | -0.3% | — | Unchanged |
| 6 | ✓ | Second Sight Med Prods INC | -0.4% | — | Unchanged |
| 7 | CRSP | CRISPR Therapeutics AG | -1.2% | -21.65% | Trim |
| 8 | AKAOQ | Achaogen INC | -1.9% | — | Unchanged |
| 9 | ✓ | Opgen, Inc. | — | NEW | New buy |